Newsroom

Strive to Deliver Breakthroughs

  1. April 24, 2018

    Harbour BioMed will give a presentation at PEGS-Boston Conference 2018

    April 30th – May 4th, 2018 Seaport World Trade Center Boston, MA Please stop by our Booth 601!   Oncology Stream   Lu...

    View more
  2. January 23, 2018

    Harbour BioMed Completes Series A+ Round Financing to Accelerate the Development of Clinical Programs and Company Growth

    January 22, 2018 SHANGHAI, China, ROTTERDAM, The Netherlands and CAMBRIDGE, MA   Harbour BioMed announced today that it has completed a Seri...

    View more
  3. January 08, 2018

    Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement with BeiGene for Fully Human Monoclonal Antibody Drug Discovery

    January 7, 2018 SHANGHAI, China, ROTTERDAM, The Netherlands and CAMBRIDGE, MA   Harbour BioMed announced today that it has licensed its pate...

    View more
  4. January 08, 2018

    Harbour BioMed Enters Agreement to Develop Fully Human Antibody Fragments for Innovative CAR-T Therapy

    January 8th, 2018 SHANGHAI, China, ROTTERDAM, The Netherlands and CAMBRIDGE, MA   Harbour BioMed announced today that it has entered into an...

    View more
  5. December 05, 2017

    Harbour Biomed will give a presentation at Antibody Engineering and Therapeutics Conference 2017 in San Diego

    Dec. 11th- 15th, 2017 Manchester Grand Hyatt San Diego, San Diego, CA Please stop by our Booth 121!    Scientific Breakfast Briefing...

    View more
  6. October 12, 2017

    Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement with Innovent Biologics, Inc. for Fully Human Monoclonal Antibody Drug Discovery

    October 12th, 2017   SHANGHAI, China, ROTTERDAM, The Netherlands and CAMBRIDGE, MA   Harbour BioMed announced today that it has lice...

    View more
  7. December 19, 2016

    Harbour BioMed Acquires Harbour Antibodies to Create Global, Oncology-focused Biotechnology Company

    Transgenic Mouse Platform Technology Licensing to Continue, Expand to Include Collaborative Discovery/Development Partnerships   Cambridge, MA, Shangh...

    View more